Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 81
Optical 75
Immune Disorders Drugs 73
Optical Disorders Drugs 68
Drug Discovery 54
Cardiovascular Drugs 46
Biopharmaceuticals 37
Dermatological Drugs 37
Musculoskeletal Disorders Drugs 37
Biotechnology 33
Genomics 28
Clinical Trials 22
Central Nervous System Drugs 19
Pharmaceuticals 19
Skin Cancer Drugs 19
Endocrine and Metabolic Disorders Drugs 19
Infectious Diseases Drugs 18
Allergy and Immunology 17
Drugs by Therapeutic Area 16
Respiratory Drugs 15
Infusions and Injectables 14
Allergy Drugs 13
Lung Cancer Drugs 12
Gastrointestinal Drugs 11
Dermatology 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Diagnostics 7
Biosimilars and Biosuperiors 7
Pharmaceutical Manufacturing 7
Prostate Cancer Drugs 6
Enzymes 6
Vaccines 6
Asthma Drugs 6
Therapeutic Area 5
Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Gastroenterology 5
Company Reports 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Cardiovascular Devices 3
Medical Devices 3
Pediatrics 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Analgesics 2
Cough and Cold Drugs 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Anti-Obesity Drugs 2
Cardiology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

682 Results (Page 30 of 35)
- Relevance
  Sort by

Checkpoint Inhibitors Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

Germ Cell Tumor Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

Targeted Therapy Market Report 2025

 Report
March 2025
175 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

Laryngeal Cancer Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

Nasopharyngeal Carcinoma Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Chronic Kidney Disease - Competitive landscape, 2023

 Report
April 2023
190 Pages
Global

From

€3107EUR$3,500USD£2,698GBP

Fibrodysplasia Ossificans Progressiva Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
86 Pages
Global

From

€3500EUR$4,224USD£3,146GBP

Solid Tumor Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

Orphan Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

$Checkpoint Inhibitor Refractory Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image$

Checkpoint Inhibitor Refractory Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
January 2025
180 Pages
Global

From

€3994EUR$4,500USD£3,469GBP

Antibody Drug Conjugate - Competitive Landscape, 2025

 Report
March 2025
450 Pages
Global

From

€4438EUR$5,000USD£3,854GBP

Anti-CD20 Antibody - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1775EUR$2,000USD£1,542GBP

Acute Pancreatitis Market - Growth, Trends, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4216EUR$4,750USD£3,661GBP

Eosinophilic Esophagitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2024
85 Pages
Global

From

€3500EUR$4,224USD£3,146GBP

Anti Asthmatic Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
101 Pages
Global

From

€3500EUR$4,224USD£3,146GBP

PD-1 and PD-L1 Inhibitors Market Report and Forecast 2025-2034

 Report
June 2025
400 Pages
Global

From

€4393EUR$4,949USD£3,815GBP

Interleukin 1 Beta Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1331EUR$1,500USD£1,156GBP

Complement C5 Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1331EUR$1,500USD£1,156GBP

United States Artificial Cornea and Corneal Implants Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
78 Pages
United States

From

€3107EUR$3,500USD£2,698GBP

Chronic Hand Eczema (CHE) - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
200 Pages
Global

From

€6657EUR$7,500USD£5,781GBP

682 Results (Page 30 of 35)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.